Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(93)
•••
Comment by Vinny57on Apr 02, 2019 4:25pm
219 Views
Post# 29572362

RE:RE:April 2nd

RE:RE:April 2nd
gottahunch wrote: I'm thinking the same. $15 if financials are decent. Should there be any Rockstar BOD news, maybe $17. Still hoping they have some kind of deal in the works. Jacob's teaser video has to mean something great is coming.
Vinny57 wrote: For those of us who think the quarterly due out on the 15th will add to the share price of this company, we only have 8 trading days left. My gut feeling is for a close above $15 at that time. This would be barring any bad news. ( I believe our 'bad' news and 'bad luck' are done with ). GGB and "the rebuttal" are history. Quarterly Reports will drive the share price. 6 and 9 months down the road is the time to take SOME profit.




BOD, yes.  But even more importantly..........a buy in.  I believe all is good.  $4.77 is long behind us now.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities